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Re-evaluation of Streptococcus 
pneumoniae carriage in portuguese 
elderly by qpcR increases carriage 
estimates and unveils an expanded 
pool of serotypes
Sónia t. Almeida1, tânia pedro1, A. cristina paulo1, Hermínia de Lencastre2,3 &  
Raquel Sá-Leão1 ✉
Streptococcus pneumoniae (pneumococcus) is a leading cause of infections worldwide. Disease is 
preceded by asymptomatic colonization of the upper respiratory tract. classical culture-based methods 
(ccBM) suggest that colonization in the elderly is <5%. Recently, use of qPCR has challenged these 
observations. We estimated pneumococcal carriage prevalence and serotypes among portuguese 
elderly using qpcR and compared results with those obtained by ccBM. nasopharyngeal and 
oropharyngeal paired samples (599 each) of individuals over 60 years living in nursing (n = 299) or 
family (n = 300) homes were screened for the presence of pneumococci by qPCR targeting lytA and 
piaB. positive samples were molecular serotyped. Use of qpcR improved detection of pneumococci 
in oropharyngeal samples compared to CCBM: from 0.7% to 10.4% (p < 0.001) in the nursing home 
collection, and from 0.3% to 5.0% (p < 0.001) in the family home collection. No significant differences 
were observed between both methods in nasopharyngeal samples (5.4% vs. 5.4% in the nursing 
homes; and 4.3% vs. 4.7% in the family homes). Twenty-one serotypes/serogroups were detected by 
qPCR compared to 14 by CCBM. In conclusion, use of qPCR suggests that pneumococcal carriage in 
Portuguese elderly is approximately 10%, and unveiled a large pool of serotypes. These results are 
important to understand progression to disease and impact of pneumococcal vaccines in the elderly.
Streptococcus pneumoniae (or pneumococcus) is a leading cause of infectious diseases worldwide, such as oti-
tis media, pneumonia, bacteremia and meningitis. The incidence of pneumococcal infections is highest at the 
extremes of age affecting disproportionally young children and the elderly1–3. This latter group is increasingly 
important in our society as the world population is aging, resulting in an increasing demand for strategies to 
maintain quality-adjusted life years in advanced ages2.
To prevent pneumococcal disease three vaccines are currently available and several are under investigation4. 
These vaccines target 10, 13, or 23 serotypes of the over 95 described to date5. The 13-valent pneumococcal con-
jugate vaccine (PCV13) is approved for all age groups and the 23-valent pneumococcal polysaccharide vaccine 
(PPV23) is approved for individuals over 2 years of age. Several countries have issued recommendations for vac-
cination of adults over 65 years of age with one or both of these vaccines1,6,7.
In Portugal, PCVs for children were commercially available through the private market until mid-2015 (PCV7 
became available in June 2001, PCV10 in April 2009, and PCV13 in January 2010). In August 2015, PCV13 was 
introduced in the National Immunization Plan for all children born after January 20158. PPV23 and PCV13 are 
commercially available for adults but its usage has been low (<10% by 2015)9,10.
Pneumococcal disease is always preceded by colonization of the upper respiratory tract, a phenomenon that 
is mostly asymptomatic11. Several studies have described high pneumococcal colonization rates (frequently over 
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60%) in young children12,13. By contrast, studies conducted in elderly populations have suggested, until recently, 
that pneumococcal colonization occurred at a very low prevalence (1–5%)14–16. These studies relied on the use of 
classical culture-based approaches in which swabs of the nasopharynx and/or oropharynx were plated in selec-
tive media and pneumococcal presumptive colonies were sub-cultured for species identification17. This strategy, 
recommended by the WHO, has a good specificity but a low sensitivity17,18.
Recently, new strategies to detect pneumococcal carriage based on real-time PCR (qPCR) have been pro-
posed, validated, and are now being increasingly used19–23. The use of qPCR enables high sensitivity in sam-
ples where pneumococci are at low density. With such approaches, carriage prevalence in the elderly has been 
re-evaluated with studies suggesting it may range between 0–20% in healthy individuals and reach approximately 
50% period-prevalence (within 7–9 weeks) in individuals with influenza-like illness20–22,24.
In Portugal, the prevalence of pneumococcal carriage among the elderly has been studied by classical 
culture-based methods only. A previous study conducted by our group estimated a carriage prevalence of 2.3%15.
The aim of this study was to re-evaluate the prevalence of nasopharyngeal and oropharyngeal colonization by 
S. pneumoniae in adults over 60 years of age using qPCR and compare the results with those obtained by classical 
culture-based approaches. We further characterized positive samples by serotyping and compared serotype dis-
tribution and diversity.
Results
pneumococcal carriage. We evaluated pneumococcal carriage by real-time PCR targeting lytA and piaB 
genes in nasopharyngeal and oropharyngeal samples from 599 adults older than 60 years of age living in nursing 
homes (n = 299) and family homes (n = 300). Socio-demographic characteristics of the population were pre-
viously described15 and are summarized in Supplementary Table S1. In general, individuals living in a nursing 
home, were older, had less years of formal education, and were less active than those living in family homes. 
Results were compared to those obtained by classical culture-based methods.
Ct values for lytA and piaB genes were not significantly different between samples from adults living in nurs-
ing homes compared to those living in family homes (adjusted GLM, p = 0.065 for lytA; p = 0.048 for piaB). 
However, in both groups, the geometric Ct mean was significantly lower in positive nasopharyngeal samples than 
in positive oropharyngeal samples (p < 0.001 for both lytA and piaB), suggesting higher quantity of pneumococci 
in the harvests of cultures originating from nasopharyngeal samples compared to those originating from oro-
pharyngeal samples (Fig. 1 and Supplementary Table S2).
The use of real-time PCR, when compared with classical culture-based methods, increased significantly the 
detection of pneumococcal carriage in oropharyngeal samples from 0.7% to 10.4% (p < 0.001) in the nursing home 
collection, and from 0.3% to 5.0% (p < 0.001) in the family home collection. By contrast, no significant differences 
were observed in carriage detection in nasopharyngeal samples when both methods were compared: 5.4% vs. 5.4% 
in the nursing home collection; and 4.3% vs. 4.7% (p = 1.0) in the family home collection (Table 1 and Fig. 2).
Overall, in adults living in nursing homes, S. pneumoniae was more frequently detected in oropharyngeal sam-
ples than in nasopharyngeal samples: 10.4% vs. 5.4% (p = 0.0093), respectively; in adults living in family homes 
no significant differences were observed between the two sampling sites: 4.7% vs. 5.0% (p = 1.0) (Table 1). When 
results of the two sampling sites were combined, the use of real-time PCR, compared to classical culture-based 
methods, increased significantly the detection of S. pneumoniae carriers from 5.7% to 12.7% (p < 0.001) in the 
nursing home collection and from 4.3% to 8.0% (p = 0.0026) in the family home collection (Table 1).
Molecular serotyping. Molecular serotyping allowed assignment of a serotype/serogroup in 70 (40 from 
oropharynx and 30 from nasopharynx) of the 76 qPCR positive samples. A single capsular type was detected in 
Figure 1. Detection of S. pneumoniae by real-time PCR in adults over 60 years of age living in nursing 
homes (A) and family homes (B). Blue circles, nasopharyngeal samples positive by culture; purple circles, 
nasopharyngeal samples negative by culture; red circles, oropharyngeal samples positive by culture; green 
circles, oropharyngeal samples negative by culture; yellow circles, positive control (S. pneumoniae TIGR4); grey 
squares, positive oropharyngeal samples in which the serotype was not determined. Dashed lines indicate the Ct 
value above which results were considered to be negative.
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67 qPCR pneumococcal positive samples and two serotypes were detected in three samples: one individual was 
co-colonized with serotypes 19A and 22A/F which were detected both in the nasopharynx and the oropharynx; 
other individual was co-colonized with serotypes 3 and 23A in the oropharynx. The six samples for which a 
serotype could not be assigned were all from the oropharynx (Fig. 1). Failure of assigning a capsular type to these 
samples suggests that they may have not been targeted by the primer set tested.
In total, twenty-one different serotypes/serogroups were detected among 76 samples that were positive for 
pneumococci by qPCR compared to 14 serotypes present in the 32 samples that were positive for pneumococci 
by classical culture-based methods. Serotype diversity (GSID = 0.897, 95% CI: 0.896–0.898) was slightly higher 
among samples detected by qPCR compared to those by classical culture-based methods (GSID = 0.879, 95% CI: 
0.877–0.881). Serotypes/serogroups 15 A/F, 24 and 38, which are not included in any pneumococcal multi-valent 
vaccine, and serotypes/serogroups 7A/F, 10A, 12A/B/F and 20 potentially targeted by PPV23 (7F is also targeted 
by PCV13), were only detected in qPCR positive samples (Table 2).
Combined nasopharyngeal and oropharyngeal sampling did not yield significantly more different serotypes 
than each sampling site alone (14 serotypes/serogroups detected in nasopharyngeal samples and 17 detected in 
the oropharyngeal samples, p = 0.166 and p = 0.564, respectively).
The most frequent serotypes/serogroups were 19A (n = 17), 23A (n = 9), 35F (n = 7), 6C/D (n = 6), 22A/F 
(n = 5) and 11A/D (n = 4), which, together, accounted for 68.6% of all serotyped samples (Table 2). Serotypes 
7B/C (n = 1), 9L (n = 1), 23B (n = 2) and 31 (n = 1) were only found in nasopharyngeal samples, while serotypes 
7A/F (n = 1), 10A (n = 1), 12A/B/F (n = 1), 15A/F (n = 1), 20 (n = 2), 24 (n = 3) and 38 (n = 1) were only found 
in oropharyngeal samples (Table 2).
Overall, among the 62 carriers (38 living in nursing homes and 24 living in family homes) a maximum of 
25.8% and 46.8% had serotypes potentially covered by PCV13, and PPV23, respectively.
Of note, within nursing homes, there was evidence of cross-transmission with a common serotype being 
frequently isolated from multiple individuals (Fig. 3). This contributed to a lower serotype diversity in the 
nursing home collection (GSID = 0.778, 95% CI: 0.775–0.782) when compared to the family home collection 
(GSID = 0.919, 95% CI: 0.918–0.920).
Discussion
In this study qPCR targeting lytA and piaB was used to investigate the prevalence of nasopharyngeal and oro-
pharyngeal pneumococcal carriage in two collections of samples obtained from adults over 60 years of age living 
in either nursing homes or family homes. Positive samples were further characterized by molecular serotyping. 
These collections were previously characterized by classical culture-based methods as part of a much larger pneu-
mococcal carriage study15.
In our previous study, as well as in studies from countries such as Belgium, Finland and Israel – which also 
used conventional culture followed by identification of presumptive colonies S. pneumoniae – pneumococcal 
carriage rates were estimated to be in the range of 3–5% among the elderly14–16,25.
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Table 1. Detection of S. pneumoniae carriers according to sampling site and methodology used. p-values 
determined using McNemar’s Chi-squared test for paired individuals.
Figure 2. Proportion of pneumococcal carriers detected by classical culture-based methods or real-time PCR. 
Red bars, adults over 60 years of age living in nursing homes; blue bars, adults over 60 years of age living in 
family homes.
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In this study, use of qPCR increased the detection of pneumococci in oropharyngeal samples by approximately 
15 times in both the nursing home and family home collections. By contrast, there was no significant added value 
in using qPCR to detect pneumococci in nasopharyngeal samples. The use of qPCR is known to be particularly 
valuable to detect pneumococci in samples that are highly polymicrobial and/or in which pneumococci are pres-
ent at low density. In oropharyngeal samples both conditions tend to be common19,20,22. The nasopharynx, by 
contrast, is known to be less polymicrobial and pneumococci, when present, tend to thrive15,26–29.
When all results were compared, pneumococci were more frequently detected in oropharyngeal samples than 
in nasopharyngeal samples (7.7% vs. 5.0%, McNemar’s, p < 0.05) and there were also twice more individuals 
positive for pneumococci exclusively in oropharyngeal samples (n = 32) compared to individuals positive exclu-
sively in nasopharyngeal samples (n = 16). These observations suggest that pneumococci, in the elderly, tend to 
preferentially colonize the oropharynx.
Serotype/
serogroup Vaccinea
Number of samples with serotype/serogroup





3 PCV13/PPV23 — — 2 3
5 PCV13/PPV23 — 1d — —
6A PCV13/PPV23 — — 2 2
6C/D — — 2 2 (6C) 4
7A/F PCV13/PPV23 — — — 1
7B/C — — — 1 1
9L — — — 1 1
10A PPV23 — — — 1
11A/D PPV23 — 3 1 (11A) 1
12A/B/F PPV23 — — — 1
15A/F — — — — 1
16F — — — 1 2
17F PPV23 1 3 — —
19A PCV13/PPV23 7 16 — 1
20 PPV23 — 2 — —
22A/F PPV23 2 (22F) 4 — 1
23A — 4 6 2 3
23B — 1 1 1 1
24 — — 1 — 2
31 — — — 1 1
35F — 3 6 1 1
38 — — — — 1
ND — — 5 — 1
Table 2. S. pneumoniae serotypes/serogroups detected in samples obtained from adults over 60 years old. 
aIndicates whether the serotype/serogroup is potentially targeted by the 13-valent pneumococcal conjugate 
vaccine (PCV13: 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F) or by the 23-valent polysaccharide vaccine 
(PPV23: 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F and 33F). 
bDetection of pneumococci by identification and characterization of presumptive colonies grown on gentamicin 
blood agar, as described in the Methods section. cDetection of pneumococci using a qPCR targeting lytA and 
piaB genes, as described in the Methods section. dGiven that this specific assay is known to yield false positive 
results, it was not taken into consideration. ND, not determined.
Figure 3. Serotype distribution of pneumococcal isolates carried by adults over 60 years of age living in nursing 
homes. Different colors indicate different nursing homes.
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They also support the recommendation that to detect pneumococci in senior adults it is important to combine 
both nasopharyngeal and oropharyngeal samples and that qPCR (targeting more than one validated gene, such 
as lytA and piaB) should be used when analyzing oropharyngeal samples19,20,22. In our study, half of the pneumo-
coccal carriers were only detected in these conditions.
Overall, we estimated that approximately 10% of the individuals were pneumococcal carriers independently 
of whether they lived in a nursing home or in a family home. These estimates are lower than those described in 
studies conducted in Italy or the Netherlands, which were closer to 20%22,24. These differences are likely to be due 
to seasonality: the latter studies were carried out in winter or winter/spring while ours took place throughout the 
year. In fact, a variation between 0–17% in pneumococcal carriage prevalence among adults over 65 years of age 
was noted in the US longitudinal study of Branche et al.21.
While we did not observe differences in density of colonization between individuals living in nursing homes 
or family homes, we observed (unsurprisingly) lower serotype diversity and evidence for cross-transmission 
within nursing homes. These are settings where individuals are often confined and where transmission of infec-
tious agents is often facilitated30.
Molecular serotyping of qPCR pneumococcal positive samples enabled assignment of a serotype/serogroup to 
most (92%) samples. Furthermore, the number of different serotypes that were detected increased by 50% (21 in 
qPCR samples vs. 14 by classical culture-based processed samples) expanding considerably the pool of serotypes 
detected in the population. This included non-vaccine serotypes and vaccine serotypes that, otherwise, would 
remain undetected and that may be important to monitor intervention strategies such as the use of pneumococcal 
vaccines.
In conclusion, carriage of pneumococci in senior adults is significantly higher than the one estimated by clas-
sical culture-based methods alone. Our current estimates suggest that, in Portugal, it is approximately 10%. The 
high number of serotypes circulating in this population and the transmission observed within nursing homes 
warrant additional studies aimed to assess its implications in disease. As the number and proportion of aged indi-
viduals increases in societies worldwide, accurate estimates of pneumococcal carriage prevalence and circulating 
serotypes in this group are crucial to better understand colonization dynamics, serotype disease potential, and 
impact of pneumococcal vaccines in this age group.
Methods
Study participants and samples. This study was nested on a study previously described15. Briefly, pneu-
mococcal carriage prevalence and associated risk factors were studied among 3,361 adults older than 60 years of 
age, between April 2010 and December of 2012. For each participant, one nasopharyngeal and one oropharyngeal 
sample were obtained. Pneumococci were isolated and identified by routine procedures based on culture-based 
methods31,32, and serotyped by conventional multiplex PCR and/or by the Quellung reaction33,34. Briefly, in the 
initial study, swabs were plated on gentamycin blood agar and incubated overnight at 37 °C in anaerobiose jars. 
On the following day, suspected pneumococcal colonies were isolated and identified by routine culture methods. 
All the remaining total bacterial growth was collected and frozen at −80 °C.
In the current study, two subsets of samples of the initial study were re-examined. One set corresponded 
to 600 paired samples (300 nasopharyngeal and 300 oropharyngeal obtained from 300 individuals) randomly 
selected from a pool previously obtained from 3,062 individuals living in family homes. The second set corre-
sponded to 598 samples (299 nasopharyngeal and 299 oropharyngeal) obtained from all individuals living in 
nursing homes at the time of the study15.
Identification and serotyping of S. pneumoniae by molecular methods. Total bacterial growth 
was thawed on ice, vortexed for 20 seconds and 200 µl were transferred into a sample tube with 200 µl of a lysis 
buffer (MagNA Pure Compact Nucleic Acid Isolation Kit, Roche Diagnostics GmbH), and incubated for 20 min 
at 37 °C. Total DNA was then extracted using the MagNA Pure Compact instrument (Roche Diagnostics GmbH) 
as recommended by the manufacturer.
Pneumococcal carriage was evaluated by real-time PCR, targeting two pneumococcal genes: lytA (major 
pneumococcal autolysin) and piaB (iron uptake ABC transporter lipoprotein PiaB)19,35. Reactions for both genes 
were performed in a final volume of 25 µl, containing 1x FastStart TaqMan Probe Master (Roche), 150 nM of 
each primer, 75 nM of probe and 2.5 µl of total DNA. DNA amplification was performed in the CFX96 Real-Time 
System Amplification (Bio-Rad) using the following conditions: 95 °C for 10 min, followed by 45 cycles of 95 °C 
for 15 sec and 60 °C for 1 min. Samples were considered positive for pneumococci when both genes had cycle 
threshold (Ct) values below 40.
S. pneumoniae capsular types were accessed in positive samples by uniplex qPCR following a pooling strategy 
as previously described36. Pools of five samples containing 2 µl of each sample were tested. Each pool was used 
as template for qPCR in a total volume of 25 µl. If a Ct<40 was obtained in a given pool of samples, these were 
tested individually for the serotype that originated the signal. In this latter case, 2.5 µl of DNA was used per reac-
tion. Samples were considered positive for a given serotype when Ct values were below 40. A panel of 23 sets of 
primers and probes was used targeting serotypes or serogroups: 1, 2, 3, 4, 5, 6A/6B/6C/6D, 7A/F, 9A/V, 11A/D, 
12A/12B/12F/44/46, 14, 15A/F, 16F, 18A/18B/18C/18F, 19A, 19F, 22A/F, 23A, 23F, 33A/33F/3737, 8, 10A/B and 
3838. Samples were considered positive for a given serotype when Ct values were below 40. Following previous 
studies that indicated that non-pneumococcal streptococci in the oropharynx can confound molecular serotyping 
assays, we disregarded positive results obtained by qPCR for serotypes 4 and 520,26,39. In addition, conventional 
multiplex PCR was used to detect serotypes 7B/7C/40, 9N/L, 15B/C, 17F, 20, 21, 23B, 24, 31, 34, 35B, 35F/47F and 
non-typeables using primers previously described33,40.
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Statistical analysis. The geometric mean was used to summarize the distribution of Ct values from lytA 
and piaB of nasopharyngeal and oropharyngeal samples. To look for associations between Ct values from nurs-
ing home vs family home and nasopharynx vs oropharynx an adjusted generalized linear model (GLM) using a 
Gaussian distribution and a log link function was used.
The McNemar’s test was used to compare culture and real-time PCR methods based on paired individuals. The 
Chi-square test was used to compare prevalence of S. pneumoniae between nasopharyngeal and oropharyngeal 
samples and between nursing home and family home by real-time PCR or culture-based methods. A p-value of 
<0.05 was considered statistically significant for all the tests used. The Gini-Simpson index of diversity (GSID) 
was used to calculate serotype diversity. All analyses were performed using R version 3.2.341.
ethics statement. This study was conducted in accordance with the European Statements for Good Clinical 
Practice and the declaration of Helsinki of the World Health Medical Association. In addition, it was registered 
and approved at health care centers of Oeiras and Montemor-o-Novo that report to Administração Regional de 
Saúde (ARS, “Regional Health Administration”) of Lisboa e Vale do Tejo, and Alentejo, respectively, from the 
Ministry of Health. Informed written consent was obtained from all participants. All samples and questionnaires 
were attributed a numeric code and were processed anonymously.
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